Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients?
DSpace/Manakin Repository
Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients?
Adams, Hugo J A; Kwee, Thomas C.
(2016) Nuclear Medicine Communications, volume 37, issue 12, pp.
(Comment)
Download/Full Text
The full text of this publication is not available.
Version on publisher website for UU-students and staff
Version on publisher website
Keywords: General Medicine, Radiology Nuclear Medicine and imaging, Letter
DOI:
https://doi.org/10.1097/MNM.0000000000000584
ISSN: 0143-3636
Publisher: Lippincott Williams and Wilkins
(Peer reviewed)